Which VC firms invest in cannabis retail chains?

If you mean VC/private-capital firms that have actually invested in cannabis companies with a substantial dispensary/retail footprint, rather than cannabis software or brands, the field is fairly specialized.

A few investors worth researching:

• West Creek Investments — A cannabis-focused VC fund that says it has invested across cultivation, manufacturing, CPG, and dispensary operations. It currently reports investments in 20 companies across two funds.
• CapStone Holdings — Invested $50 million in Curaleaf in 2020 and described itself as one of the largest investors in Curaleaf's $300 million senior loan facility. Curaleaf has developed one of the largest U.S. retail dispensary networks.
• Verdant Capital Partners — A newer cannabis-focused investment platform explicitly pursuing a scaled cannabis retail strategy. It acquired the retail operations of Colorado's Native Roots in July 2026 and says its strategy is to acquire, operate, and grow cannabis retail businesses.

If you're raising for a cannabis retail chain

I'd distinguish between three investor categories:

The last category is particularly important. Companies such as Verano, Curaleaf, Green Thumb, Trulieve, and Vireo have built substantial retail networks, so they can be potential strategic capital or acquisition/JV counterparties rather than conventional VC investors. For example, Verano reported 163 operational retail locations across 13 states as of its 2026 investor materials.

There is also increasing consolidation at the retail-platform level: in April 2026, Vireo and Glass House announced a 50/50 California retail joint venture combining 12 Vireo dispensaries with 11 Glass House locations.

If you're asking because you operate (or are building) a cannabis dispensary chain and want a fundraising target list, I can give you a much more useful list of 20–30 specific VC/PE firms, their typical check sizes, geography, retail investments, and whether they're currently active in 2026.

Investing in cannabis retail chains (dispensaries and brick-and-mortar storefronts) involves navigating complex federal and state regulatory frameworks, particularly in the United States, where cannabis remains federally illegal. Because of this, many generalist VCs shy away from "plant-touching" retail, leaving specialized cannabis venture capital, private equity, and institutional investment firms to lead the charge.

Prominent VC and private equity firms that invest across the cannabis value chain, including retail chains, multi-state operators (MSOs), and dispensary networks, include:

• Entourage Effect Capital — A dedicated cannabis-focused venture capital firm that invests broadly across the legal cannabis market, including distribution, retail operations, and supply-chain infrastructure.
• Merida Capital Holdings — A private equity/VC hybrid targeting foundational pillars of the cannabis ecosystem, with a portfolio spanning major cultivators, brands, and retail-focused operators like Cresco Labs and Jushi.
• Casa Verde Capital — One of the most prominent early-stage and growth-stage cannabis VC funds. While they lean heavily into ancillary technology and B2B platforms (like LeafLink and Eaze), they play a major strategic financing role within the broader consumer and retail ecosystem.
• Green Acre Capital — A specialized private cannabis fund originating in Canada that expanded its mandate to US and international opportunities, directly investing across brands, retail storefronts, and extraction.
• Key Investment Partners — An active cannabis-focused venture capital firm that targets early-stage innovations, lifestyle brand platforms, and licensed retail/dispensary networks.
• Gotham Green Partners — A large-scale private equity and venture firm providing growth capital and buyout funding across cultivation, processing, branding, and distribution channels in the North American cannabis market.
• Measure 8 Ventures — A cannabis-focused VC fund making concentrated investments across the entire value chain, focusing heavily on brand-building, retail consolidation, and multi-state operations.
• Altitude Investment Management — A private investment firm specializing in the legal cannabis industry, participating in growth-stage rounds for plant-touching operators, consumer brands, and technology platforms.

If you mean VC firms that invest directly in cannabis dispensary/retail operators (plant-touching retail chains) rather than cannabis software, brands, or ancillary businesses, the list is relatively small. Traditional VC has generally avoided direct cannabis retail because of regulatory risk, licensing complexity, and capital intensity; much of the funding has come from cannabis-focused funds, growth equity firms, family offices, private equity, and strategic operators.

Some investors to look at:

A few non-VC capital sources that are often more relevant for cannabis retail chains:

• Verdant Capital Partners — an investment/operator platform focused specifically on acquiring and scaling cannabis retail businesses, including the acquisition of Native Roots Cannabis Co. retail operations.
• Cannabis-focused private equity and credit investors often finance multi-store rollups because dispensaries require significant real estate, licensing, inventory, and working capital.

If you are raising capital for a cannabis retail chain, the most likely targets are usually:

1. Cannabis-focused funds (Poseidon, Casa Verde, Green Acre, etc.)
2. Cannabis private equity/growth investors
3. Strategic MSOs (multi-state operators) seeking acquisitions or partnerships
4. Real-estate-backed cannabis lenders and sale-leaseback providers

For a dispensary chain specifically, I would distinguish between:

• Seed/early-stage: cannabis VCs and operator angels
• 5–20 store expansion: growth equity, family offices, cannabis PE
• Multi-state rollup: strategic MSOs and institutional capital

If you want, I can also provide a list of 25+ cannabis investors that have funded dispensary operators, with check sizes and example deals.

Investing in cannabis retail chains (dispensaries) differs from standard venture capital. Due to federal illegality in the United States, traditional tier-1 VCs (like Sequoia or Andreessen Horowitz) historically avoided direct-touch plant operations, leaving the space to specialized cannabis private equity (PE), venture capital (VC) funds, and multi-state operator (MSO) financiers.

Furthermore, true "retail chains" (Multi-State Operators or large regional dispensary footprints) are typically too capital-intensive or late-stage for seed/early VC, leaning more heavily on private equity, structured debt, and growth capital. However, several dedicated cannabis investment firms and specialized VCs actively fund retail, direct-to-consumer (DTC) storefronts, and dispensary infrastructure:

• Entourage Effect Capital (formerly Cresco Capital Partners) : A prominent private equity and growth-stage VC firm that focuses heavily on the cannabis ecosystem, including operators touching the plant, wellness brands, and retail-adjacent medical/recreational dispensaries (such as investments in Curio Wellness and Organic Remedies).
• Gotham Green Partners : A large-scale private equity/VC firm based in New York that deploys massive amounts of capital globally into cannabis enterprises, frequently backing large cultivation, processing, and retail/distribution networks.
• Altitude Investment Management : A global venture capital fund investing across the cannabis value chain, including retail tech, compliance, supply chain infrastructure, and select operational entities that feed or support the dispensary ecosystem.
• Green Acre Capital : A Canadian private investment fund that has targeted medical and recreational retail infrastructure, brands, and dispensaries, particularly during the explosive rollout of Canada's legal retail market.
• Casa Verde Capital : Founded with a focus on high-growth ancillary businesses rather than direct-touch plant operations (dispensaries themselves), they are worth noting because they invest heavily in the retail technology , data, logistics, and point-of-sale systems that power cannabis retail chains.

Key Distinction in Cannabis Retail Investing:

If you are looking at retail chains specifically, the lines blur between Venture Capital and Private Equity / MSO Consolidation . Most large retail chains scale either by going public (via the Canadian CSE or OTC exchanges), raising private debt, or taking institutional PE money from dedicated sector funds rather than standard venture capital rounds.

Investing in cannabis retail chains (dispensaries) requires navigating complex state-by-state and federal regulatory frameworks (such as 280E tax constraints and lack of federal legalization in the U.S.). Because of this, traditional venture capital (VC) firms often split their focus between direct plant-touching retail operators and "ancillary" tech/logistics companies.

A mix of specialized venture capital and private equity firms actively invest in or finance cannabis retail chains and multi-state operators (MSOs):

• Merida Capital Holdings
  A private equity and venture firm that targets the foundational growth drivers of the cannabis ecosystem. Unlike firms that strictly avoid plant-touching operations, Merida has actively invested in and partnered with cultivation and dispensary retail portfolios (such as backing regional retail chains like 3Fifteen Cannabis and operators like Skymint).
• Entourage Effect Capital (EEC)
  Formerly known as Cresco Capital Partners, this investment firm focuses heavily on the cannabis value chain, deploying capital into growth-stage businesses, including localized retail storefronts, brands, and distribution networks.
• Poseidon Asset Management
  One of the longest-running investment firms in the cannabis space, Poseidon takes a diversified approach across the sector, evaluating both ancillary tech and direct-to-consumer/retail positioning where state regulations permit.
• Altitude Investment Management
  A global cannabis-focused venture capital fund investing across the supply chain, which includes consumer brands, technology platforms, and retail-enabling infrastructure.
• Navy Capital
  A prominent investment firm targeting best-in-class operators in the cannabis industry, frequently participating in financing rounds for vertically integrated multi-state operators (MSOs) that manage extensive retail footprints.
• Casa Verde Capital (Notable Exception / Ancillary Focus)
  Co-founded by Snoop Dogg, Casa Verde is the most prominent VC firm in cannabis, but it explicitly avoids investing directly in plant-touching retail dispensaries. Instead, they fund the retail infrastructure —such as e-commerce and point-of-sale software provider Dutchie or B2B platforms like LeafLink . Keep this distinction in mind when pitching firms, as many pure-play VCs follow this ancillary-only model.

Key Considerations for Retail Raising:

• Multi-State Operators (MSOs): Larger retail chains often raise capital via private equity (PE), structured debt, or public markets (Canadian CSE or OTC exchanges) rather than traditional early-stage VC funds.
• Ancillary vs. Plant-Touching: If you are looking for pure retail storefront investment, look toward specialized cannabis private equity (Merida Capital, Entourage Effect Capital ) rather than generalist or strict-ancillary cannabis VCs.

Yes. If you mean VC/PE firms that have actually put capital into cannabis retail/dispensary operators, rather than cannabis software or ancillary businesses, the universe is relatively small. Cannabis retail has historically attracted more private equity, family-office, and strategic capital than conventional Silicon Valley-style VC.

Some of the investors/platforms worth looking at:

• Merida Capital Holdings — Cannabis-focused investment firm with a history of investing across the cannabis value chain, including plant-touching businesses. It is more PE/growth-capital oriented than traditional VC.
• Poseidon Garden Ventures / Poseidon Asset Management — One of the better-known cannabis investment platforms; has invested across cannabis companies, including operators and retail-related businesses.
• Entourage Effect Capital — Cannabis-focused private investment firm with investments spanning cultivation, brands, technology and retail/consumer businesses.
• Casa Verde Capital — Cannabis-focused VC fund founded by Snoop Dogg. Primarily known for early-stage cannabis and ancillary investments, but worth approaching if the retail chain has a differentiated consumer/technology component.
• AFI Capital Partners — Cannabis-focused investment firm that has participated in financing cannabis operators and growth businesses.
• Merida / institutional cannabis capital — Particularly relevant if you're looking for growth capital for multi-location expansion, rather than a seed round.

There are also strategic investors/operators that effectively function as capital providers for retail rollups. For example, AYR Wellness operates a large retail footprint and has historically pursued acquisitions and consolidation. As of December 2024, AYR reported 97 retail stores across its portfolio.

A particularly interesting newer entrant is v3rdnt.com, which explicitly describes itself as an investment/operating company focused on acquiring and growing cannabis retail businesses. In 2026 it acquired the retail operations of Native Roots, consisting of 17 Colorado dispensaries.

If you're raising capital for a cannabis retail chain

I'd divide your target list into three buckets:

1. Cannabis-focused PE/growth investors — best for $10M+ expansion, acquisitions, or multi-state rollups.
2. Cannabis VC funds — better if you're earlier-stage and have a strong technology, brand, or consumer proposition alongside the stores.
3. Family offices / cannabis operators — potentially the most realistic source for individual-store acquisitions and state-license expansion.

One important distinction: a fund saying it invests in “cannabis” does not necessarily mean it will invest in dispensaries. Many cannabis VCs deliberately avoid plant-touching businesses because of regulatory, banking, and capital-structure issues. AYR itself noted historically that institutional PE/VC capital had been cautious toward cannabis, although private financing from family offices and HNW investors had become more available.

If you tell me (a) how much you're raising, (b) which state(s), (c) number of existing/proposed stores, and (d) whether you already have licenses, I can build you a target list of 20–30 specific VC/PE/family-office investors that have demonstrated willingness to fund cannabis retail, including their typical check size and relevant portfolio companies.

Investing in cannabis retail chains (often structured as Multi-State Operators, or MSOs, in the U.S.) involves a distinct mix of venture capital (VC), private equity (PE), and specialized sector-focused funds.

Because cannabis remains federally illegal in the United States, traditional mainstream VC firms rarely touch plant-touching retail directly. Instead, specialized cannabis funds, private equity groups, and strategic investment firms drive the funding for dispensary footprints and retail rollouts.

Key institutional and specialized investment firms active in backing cannabis retail operations and dispensary networks include:

• Merida Capital Partners: A private equity and venture firm that actively targets plant-touching opportunities, including cultivation, distribution, and retail dispensary chains. For example, Merida backed retail portfolios like 3Fifteen Cannabis (expanding prominent retail footprints in states like Michigan).
• Gotham Green Partners: A prominent private equity and venture firm focused on the global cannabis value chain. They are known for writing massive check sizes to scale operators, including multi-million-dollar strategic investments in major retail and vertically integrated operators like iAnthus Capital Holdings to accelerate dispensary build-outs.
• Casa Verde Capital: Founded as a leading VC firm focused exclusively on the cannabis ecosystem. Note: Casa Verde historically centered its thesis primarily on ancillary, non-plant-touching businesses (like data, compliance software, and financial services) to bypass federal restrictions, but they operate as a dominant force enabling the broader infrastructure that retail chains rely on.
• Poseidon Investment Management: One of the earliest institutional cannabis investment firms managing private funds. While they invest heavily across the operational and technological stack (such as supply chain and ERP software for operators), they track and finance the evolution of the retail landscape closely.
• Entourage Effect Capital: A specialized private equity and venture capital firm investing across the cannabis supply chain, including brand building, distribution, and retail/dispensary infrastructure.

Why Direct Retail VC Investment is Unique

1. The MSO Structure: Most large-scale retail chains in the U.S. go public on Canadian exchanges (like the CSE) or raise late-stage private equity/debt rather than traditional early-stage VC funding because scaling a brick-and-mortar footprint across state lines is heavily capital-intensive.
2. Ancillary vs. Plant-Touching: Traditional VC funds that want lower regulatory risk stick to B2B SaaS, compliance, e-commerce, and delivery logistics for dispensaries, whereas dedicated cannabis private equity handles the heavy lifting of real estate, licensing, and retail storefront acquisition.

Yes. If by cannabis retail chains you mean multi-location, plant-touching dispensary operators—not just cannabis software or brands—the investor universe is narrower than general cannabis VC.

Strongest targets

• Poseidon Asset Management — Probably the clearest fit. Poseidon explicitly invests in vertically integrated operators including retail, and its portfolio includes Ascend Wellness, Groundworks Industries, SPARC, and Sunburn Cannabis. Its Garden Fund is also making investments directly into dispensaries.
• Merida Capital Holdings — More private equity/growth capital than traditional VC, but highly relevant for a scaling retail chain. Merida has invested across the cannabis supply chain and has specifically owned/invested in retail operators such as 3Fifteen Cannabis.
• West Creek Investments — Boutique cannabis VC with investments spanning cultivation, CPG, fintech and dispensary operations. It says it currently has investments in 20 companies across two funds.
• Casa Verde Capital — One of the better-known dedicated cannabis VCs. Its strategy is broader than retail, so I'd consider it a secondary target for a dispensary chain, particularly if the company has a differentiated consumer/brand angle or technology component. Current investor databases continue to rank it among the most active U.S. cannabis VC funds.
• Phyto Partners — Cannabis-focused VC with a broad technology/consumer investment thesis. More attractive if your retail model has a strong technology, data, or consumer-brand component.

A particularly interesting signal

Poseidon has recently become more explicitly interested in retail. In December 2024, it announced investments in two New Jersey dispensaries, saying it was allocating capital to retail "special situations" with an emphasis on profitability and faster investor returns. PR Newswire It also invested in Sunburn, which operates a large Florida retail footprint.

So if you're raising for an existing dispensary chain with multiple stores and a path to EBITDA, I'd put Poseidon near the top of the outreach list.

How I'd segment the investor search

If you're raising capital for a cannabis retail chain, I can also build you a target list of 25–50 investors that actually invest in plant-touching retail, including fund size, typical check size, stage, portfolio companies, geography, and partner/contact names—which would be much more useful than a generic cannabis VC list.

Investing in plant-touching cannabis retail chains (dispensaries) differs significantly from traditional tech venture capital due to federal illegality in the United States. Many early cannabis VCs historically avoided direct "brick-and-mortar" plant-touching retail, focusing instead on ancillary software, logistics, or biotech.

However, several specialized private equity and venture/growth capital firms do invest directly in retail operators, multi-state operators (MSOs), and dispensary chains, or have evolved their mandates to include plant-touching retail.

Prominent firms that have targeted or actively invest across the cannabis retail and dispensary ecosystem include:

• Merida Capital Holdings - A private equity firm targeting fundamental growth drivers in the cannabis space. Their past and present portfolio includes major plant-touching multi-state operators and retail-adjacent players like Cresco Labs and Jushi Holdings.
• Entourage Effect Capital (formerly Cresco Capital Partners) - A growth equity and venture firm dedicated to the cannabis industry since 2014. They invest across the supply chain, including cultivation, distribution, and retail/dispensary networks.
• Gotham Green Partners - A private equity and venture firm based in California that deploys capital globally into cannabis enterprises. They have historically backed high-profile retail and brand players, including investments touching major dispensary and retail footprints like MedMen.
• Green Acre Capital - A dedicated cannabis fund (operating heavily out of Canada with international/US scope) that explicitly includes retail stores and consumer brands in its mandate. They notably achieved early successful exits in retail brands like Tokyo Smoke.
• Altitude Investment Management - A global venture capital fund investing across the cannabis value chain, including maturation-stage and retail-focused operators in the U.S. and international markets.
• AFI Capital Partners - While initially focused on capital-efficient ancillary plays, they expanded their strategy into plant-touching operations (such as medical cannabis providers and cultivation/dispensary networks) when finding scalable profit paths.

Note: Traditional pure-play tech VC firms generally steer clear of physical retail dispensary chains due to regulatory complexities. Most direct retail chain expansion is instead funded by specialized cannabis private equity, high-net-worth angel syndicates (such as The Arcview Group ), or public market capital raising.

Yes. If by “cannabis retail chains” you mean operators that own/operate multiple dispensaries—rather than cannabis software, brands, or cultivation-only businesses—the investor universe is narrower than the broader cannabis VC market.

VC / growth investors worth targeting

• Poseidon Investment Management — One of the strongest fits. Its Garden Fund explicitly invests across licensed operators, including retail, and it has backed multi-location operators such as Sunburn Cannabis.
• Gotham Green Partners — Particularly relevant for larger, established retail platforms. It provided a $250M secured convertible facility to MedMen, explicitly describing MedMen as a leading U.S. cannabis retailer.
• Entourage Effect Capital — A major cannabis-focused investment platform with $140M+ deployed across 60+ portfolio companies. It invests in plant-touching businesses and is currently deploying its third fund toward companies positioned to scale ahead of federal legalization.
• Merida Capital Partners — More growth/private-equity oriented than a classic seed VC, but worth approaching if the retail chain has meaningful revenue, licenses, and a consolidation strategy. It is consistently identified among the major cannabis-focused investment firms.
• Casa Verde Capital — One of the best-known dedicated cannabis funds. It can participate across financing stages, although its historical emphasis has leaned toward scalable, capital-efficient businesses and ancillary/technology companies rather than capital-intensive retail.
• Phyto Partners — Cannabis-focused VC with a broad portfolio; potentially relevant depending on the chain's stage and capital requirements.
• Navy Capital — Cannabis-focused investor with exposure across the industry; more appropriate to investigate for growth-stage opportunities than a very early retail startup.

The important distinction

For a dispensary chain, I'd prioritize investors with demonstrated willingness to finance “plant-touching” operators. Traditional Silicon Valley-style VCs often avoid the category because cannabis retail is capital intensive, heavily regulated, and geographically fragmented.

A particularly interesting recent example is Poseidon's investment in Sunburn Cannabis: Sunburn operates multiple Florida retail locations, and Poseidon made an initial investment in 2022 followed by another investment in 2024.

If you're raising capital for a cannabis retail chain, I can also build you a more useful 2026 investor target list of ~25 funds, ranked by (1) actual dispensary/retail investments, (2) typical check size, (3) stage, (4) states they invest in, and (5) contact/partner to approach.